Wang's research team found that the HSP90 inhibitor AUY922 suppresses the growth of KRAS-mutant CRC xenografts by inducing apoptosis associated with endoplasmic reticulum (ER) stress. The gene discussed is KRAS; the disease is colorectal carcinoma.